RAMP3 and neoplasm: Nault et al., published a five-gene score based on the expression of HN1, RAN, RAMP3, KRT19, and TAF9 that could predict prognosis (overall survival, early tumor recurrence, and risk of death after recurrence) in patients after resection more accurately than previously reported molecular signatures [44].